Crinetics Pharmaceuticals (CRNX) Operating Income Growth (3y) (2020 - 2026)
Crinetics Pharmaceuticals (CRNX) Operating Income Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn | 69.02% |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn | 55.96% |
| 10 | Crinetics Pharmaceuticals | 8.72 Bn | 7.43 Bn | 10.53 Mn | -43.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.03% |
| Dec 31, 2025 | -41.13% |
| Sep 30, 2025 | -48.60% |
| Jun 30, 2025 | -44.22% |
| Mar 31, 2025 | -48.78% |
| Dec 31, 2024 | -45.30% |
| Sep 30, 2024 | -46.70% |
| Jun 30, 2024 | -46.95% |
| Mar 31, 2024 | -47.49% |
| Dec 31, 2023 | -42.20% |
| Sep 30, 2023 | -47.31% |
| Jun 30, 2023 | -46.29% |
| Mar 31, 2023 | -39.22% |
| Dec 31, 2022 | -46.21% |
| Sep 30, 2022 | -41.84% |
| Jun 30, 2022 | -47.75% |
| Mar 31, 2022 | -49.89% |
| Dec 31, 2021 | -48.51% |
| Sep 30, 2021 | -51.04% |
| Jun 30, 2021 | -66.20% |